“…In summary, the potential quality markers of XKST were preliminarily identified as danshensu, salvianolic acid B, salvianolic acid A, puerarin, and daidzein. Studies have shown that danshensu, salvianolic acid B, and puerarin have the activity of inhibiting free radical production and antioxidants and play a definite role in the treatment of CVDs ( Lam et al, 2007 ; Wu et al, 2008 ; Zhao et al, 2008 ; Chen et al, 2011 ; Xue et al, 2014 ; Li et al, 2020 ; Wang et al, 2020 ). Meanwhile, danshensu, salvianolic acid B, salvianolic acid A, puerarin, and daidzein all have been noted that they can reduce myocardial injury in a rat ischemia/reperfusion model ( Kim et al, 2009 ; Yin et al, 2013 ; Xue et al, 2014 ; Wang et al, 2020 ; Ling et al, 2021 ).…”